home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

An Introduction to Signal Detection and Data Mining: FDA and Industry Perspectives

 
  February 08, 2007  
     
 
Drug Information Association, Online
Feb 27 2007


Special Encore Presentation of the highly acclaimed, “Signal Detection, Case Assessment, and Data Mining in Pharmacovigilance: Current State of the Art,” from the 6th Annual DIA Conference for Contemporary pharmacovigilance and Risk Management Strategies

Participate in a theoretical and methodological review of the application of data mining techniques to safety surveillance, its application in signal detection, and the critical role of clinical case assessment.

WEBINAR HIGHLIGHTS
•Approaches to signal detection and use of data mining techniques
•Comparison of approaches for large and small companies
•Use of data mining by FDA.

 
 
Organized by: Drug Information Association
Invited Speakers: STEVE JOLLEY
Vice President, Pharmacovigilance
TARATEC.
 
Deadline for Abstracts: -
 
Registration: http://www.diahome.org/product/13517/07204.pdf
E-mail: dia@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.